Another intriguing observation was the significant differences in the expression levels of SP100 family members across different immune subtypes of PAAD: SP100/SP110/SP140L displayed the highest expression in C2 subtype PAAD tissues, while the lowest expression was observed in C3 subtype PAAD tissues (Figure 5G). This evidence concerns the gene SP100 and pancreatic adenocarcinoma.